• Tomivosertib in Human DRG Neuron Excitability

  2026-09-21

  The reference study tested MNK inhibition directly in cultured human dorsal root ganglion neurons obtained during surgery for radiculopathy, showing that tomivosertib rapidly and reversibly suppresses spontaneous activity in neurons likely to be nociceptors. By pairing electrophysiology with eIF4E phosphorylation measurements, the work provides translational evidence for MNK signaling in human neuropathic pain while stopping short of demonstrating clinical analgesic efficacy.

• tFUS, Nespas/miR-383-3p/SHP2, and Stroke

  2026-09-21

  This reference study shows that low-intensity transcranial focused ultrasound stimulation (tFUS) reduces post-stroke neuroinflammation and neurological injury in a rat ischemic stroke model. Its central contribution is the identification of a Nespas/miR-383-3p/SHP2 regulatory axis that links neuromodulation with suppression of microglial NLRP3 inflammasome activity.

• Gamithromycin PK/PD Workflow for Respiratory Research

  2026-09-20

  Build more predictive respiratory infection assays with Gamithromycin by pairing serum-aware susceptibility testing with lung-focused PK/PD analysis. This workflow translates the strongest evidence for ML-1709460 into practical experimental design, troubleshooting, and translational decision points.

• Concanamycin A: From pH Control to Translational Insight

  2026-09-19

  A mechanistic and translational perspective on Concanamycin A as a V-type H+-ATPase inhibitor, connecting endosomal acidification, tumor-cell phenotypes, and emerging lessons from ceramide phosphoregulation.

• I-BET151: From BET Binding to Cell Death

  2026-09-18

  I-BET151 (GSK1210151A) is examined as a mechanistic probe connecting BET-dependent transcription with cancer cell-state decisions. This article translates prostate cancer super-enhancer findings into a rigorous assay strategy while separating established evidence from testable hypotheses.

• Plant Protein Secretion: Methods, Innovation, and Impact

  2026-09-18

  Plant Protein Secretion: Methods and Protocols, Second Edition, advances the field by organizing conventional and unconventional secretion workflows around plant-specific endomembrane biology. Its main practical contribution is a reproducible, troubleshooting-oriented framework for comparing trafficking routes across plant cell types without importing assumptions from yeast or mammalian systems.

• Concanamycin A: V-ATPase Workflow for Cancer Research

  2026-09-17

  Concanamycin A converts V-ATPase-dependent proton transport into a controllable variable for studying lysosomal stress, apoptosis, trafficking, and tumor-cell invasion. This workflow connects acute pharmacological inhibition with the AMPK–SQSTM1/p62–NRF2 feedback circuitry described in recent metabolic-stress research.

• Fucoidan, Caveolin-1, and MCF-7 Breast Cancer Cells

  2026-09-17

  This reference study identifies caveolin-1 regulation as a previously underexplored component of fucoidan activity in MCF-7 breast cancer cells. By combining cytotoxicity, membrane integrity, colony formation, migration, and protein-expression assays, the work suggests that algal fucoidan can suppress several tumor-associated phenotypes, while also clarifying the limits of translating in vitro findings into therapeutic claims.

• Difloxacin HCl: From Mechanism to Assay Design

  2026-09-16

  Difloxacin HCl is a quinolone antimicrobial antibiotic with applications spanning bacterial DNA replication inhibition and multidrug resistance research. This article develops a mechanism-to-assay framework that separates validated compound activity from checkpoint biology and improves experimental interpretation.

• CK2–LOH2 Phosphoregulation of Plant Ceramides

  2026-09-16

  The reference study identifies casein kinase 2 (CK2) as a post-translational regulator of the Arabidopsis ceramide synthase LOH2. Phosphorylation increases LOH2 catalytic activity while accelerating its ubiquitin-dependent degradation, thereby tuning C16 ceramide production, salicylic acid accumulation, and plant immune responses.

• (-)-Blebbistatin in Mechanomemory Assays

  2026-09-15

  (-)-Blebbistatin is a selective non-muscle myosin II inhibitor for dissecting actomyosin-dependent mechanotransduction. This article translates new mechanomemory findings into practical assay-design decisions, controls, and interpretation strategies.

• Tamoxifen Beyond the Label: Safer Translational Design

  2026-09-15

  Tamoxifen is more than an estrogen receptor antagonist or a CreER trigger: it is a context-dependent signaling reagent whose benefits and liabilities must be interpreted across tissue, dose, developmental stage, and assay design. This thought-leadership analysis connects breast cancer research, CreER-mediated gene knockout, prostate carcinoma cell growth inhibition, and emerging antiviral observations with practical guidance for more rigorous translational workflows.

• Mitochondrial TERC-53 as a Senescence Signal

  2026-09-14

  The reference study identifies mitochondrion-processed TERC-53 as a retrograde signal that regulates cellular senescence and age-related cognitive decline without changing telomerase activity. Its perturbation-based design separates a noncanonical RNA signaling function from TERC’s established role in telomere maintenance, offering a framework for studying mitochondrial control of ageing.

• Everolimus (RAD001) Cancer Assay Workflows

  2026-09-14

  Build more informative mTOR inhibition experiments with Everolimus (RAD001), from solvent handling and dose design to pathway and cell-death readouts. The workflow separates growth arrest from killing, helping cancer researchers interpret renal, ovarian, and other tumor models without mistaking reduced metabolic signal for apoptosis.

• AO/PI Staining Solution for Cell Counting

  2026-09-13

  AO/PI Staining Solution uses two fluorescent DNA dyes to distinguish membrane-intact and membrane-compromised cells. The dual-signal design supports fluorescence-based cell counting while limiting debris and red-blood-cell interference described for conventional viability workflows.

8401 records 1/561 page Next 12345 下5页 Last page